Long-term outcomes based on time-to-angiography in patients admitted with non-ST-segment elevation acute coronary syndromes

Journal of Invasive Cardiology

Volumn 17, Issue 5, 2005, Pages 251-255

  Al Mallah, Mouaz ^a   Dajani, Khaled ^a   Hudson, Michael ^a   Iyengar, Hrishikesh ^a   Gutierrez, Noel ^a   Weaver, W Douglas ^a   Khanal, Sanjaya ^a  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

Acute coronary syndrome; Coronary angiography; Outcome

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; SURVIVAL RATE;

AGE FACTORS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 18244366852     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Braunwald E, Amman E, Beasley J, et al. AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendation. J Am Coll Cardiol 2002:40:1366-1374.
2. Wallenrin L, Lagerqvist B, Husted S. et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomized trial. Lancet 2000;356:9-16.
3. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887.
4. Fox K, Poole-Wilson P, Henderson R, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: The British Heart Foundation RITA 3 randomized trial. Lancet 2002;360:743-751.
5. Yusuf S, Flather M, Pogue J, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST-elevation. OASIS (Organization to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet 1998;352:507-514.
6. McCullough P, Gibson C, Dibattiste P, et al. Timing of angiography and revascularization in acute coronary syndromes: An analysis of the TACTICS-TIMI-18 trial. J Intervent Cardiol 2004;17:81-86.
7. Neumann F, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes. JAMA 2003;290:1593-1599.
8. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial. Thrombolysis in Myocardial Ischemia. Circulation 1994;89:1545-1556.
9. McCullough PA, O'Neil WW, Graham M, et al. A time to treatment analysis in the Medicine versus Angiography in thrombolytic (MATE) Trial. J Intervent Cardiol 2001;14:415-422.
10. American Heart Association, Heart and Stroke Statistics - 2004 update. Dallas, Texas. American Heart Association, 2004.
11. Baigent C, Collins R, Appleby P, et al. ISIS-2: 10-year survival among patients withsuspected acute MI in randomized comparison of intravenous streptokinase, oral aspirin, both or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. British Med J 1998;316:1337-343.
12. Yusuf S, Zhao F, Mehta SR, et al. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-elevation. N Engl J Med 2001;345:494-502.
13. Boersma E, Akkerhuis KM, Theroux P. et al. Platelet glycoprotein IIb/IIIa receptor inhibitor in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention, Circulation 1999;100:2045-2048.
14. Cannon CP, Braunwald E, McCabe CH, et al. Pravastatin or atorvatatin evaluation and infection yherapy-yhrombolysis in myocardial intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1493-1504.
15. Bhatt DL, Roe MT, Peterson ED, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative. 2004;292:2096-2104.
16. Fox KA, Goodman SG, Anderson FA, et al. From guidelines to clinical practice: The impact of hospital and geographical trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24:1414-24.